Hims & Hers Health, Inc. HIMS has built its model around a tightly integrated digital platform that connects patients with licensed healthcare providers while managing the full care journey end-to-end. Its services combine telehealth consultations, electronic medical records, digital prescriptions and pharmacy fulfillment into a single, streamlined experience, enabling users to move seamlessly from diagnosis to treatment and ongoing care. The platform is designed to support personalized treatment plans and continuous engagement, with patients accessing services through web and mobile interfaces while providers deliver care remotely.
This technology-first approach is increasingly being enhanced through deeper investments in data and artificial intelligence (AI). HIMS has emphasized building a next-generation healthcare platform powered by AI to enable more intelligent routing, improved diagnosis and highly personalized care delivery at scale. By integrating data-driven tools across its ecosystem, Hims & Hers aims to standardize high-quality care while maintaining a tailored experience for individual users.
Recent developments further reinforce the role of the platform as the central connector between patients, providers and treatment access. Partnerships with pharmaceutical companies have expanded the availability of FDA-approved medications directly through the platform, while new offerings such as advanced diagnostics, multi-cancer early detection testing and holistic Labs experiences extend its capabilities beyond consultations into proactive and preventive care. Together, these initiatives deepen Hims & Hers’ platform’s role in linking patients to providers and a broader ecosystem of healthcare solutions in a more accessible and coordinated manner.
Hims & Hers is scheduled to report first-quarter 2026 results on May 11, after the closing bell.
LFMD & AMWL Enable Platform-Led Virtual Care
LifeMD, Inc. LFMD leverages a vertically integrated digital platform to connect patients with providers through virtual consultations, diagnostics and pharmacy services, enabling a seamless end-to-end care experience. LifeMD facilitates continuous engagement via its nationwide provider network and proprietary technology infrastructure. Recently, LifeMD expanded its platform capabilities with the launch of Novo Nordisk’s oral Wegovy and the addition of Eli Lilly’s Foundayo, reinforcing its role in delivering accessible, technology-enabled care solutions to patients.
American Well Corporation AMWL, popularly known as Amwell, operates a comprehensive technology platform that connects patients with providers across virtual, in-person and automated care settings, enabling integrated and efficient healthcare delivery. Amwell empowers health systems and payers to deliver hybrid care through its scalable, API-driven infrastructure and deep integrations with clinical workflows. Amwell has also extended its Digital First contract with the U.S. Defense Health Agency, highlighting its continued role in enabling seamless, technology-driven care for a large patient population.
HIMS’ Price Performance, Valuation and Estimates
Shares of Hims & Hers have lost 34.9% year to date, underperforming the industry’s decline of 27.1%.
Image Source: Zacks Investment Research
HIMS’ forward 12-month P/S of 1.6X is lower than the industry’s average of 3.2X and its five-year median of 2.6X. It has a Value Score of C.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for HIMS’ 2026 earnings per share suggests a 15.1% improvement compared with 2025.
Image Source: Zacks Investment Research
Hims & Hers currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Beyond Nvidia: AI's Second Wave Is Here
The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.
SeeWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
American Well Corporation (AMWL): Free Stock Analysis Report
Hims & Hers Health, Inc. (HIMS): Free Stock Analysis Report
LifeMD, Inc. (LFMD): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).